Article · 29 Aug 2026
Conference abstract
Opportunities to increase pertussis and measles vaccine uptake
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: Tuberculosis is a serious health problem in developing countries. One way to overcome this is to offer immunization to all newborns using BCG vaccine. BCG vaccine is safe but known to be associated with complications. The aim of this report was to evaluate the safety of BCG vaccine in Eastern Province, Saudi Arabia and outline our management for BCG vaccine related complications. Methods: The records of infants with BCG vaccine complications were retrospectively reviewed for: age, sex, birth weight, gestation, presentation, treatment and outcome. All were immunized (BCG vaccine SSI, Copenhagen, Denmark, 0.05 ml injected intradermally in the left arm by a constant group of 3 trained nurses) within 48 hours after birth. Results: Over a 3 years period (10.3.2008 to 10.3. 2011), 26,000 newborns received BCG immunization and 81 (51 M and 30 F) developed complications. This gives an incidence of 3.12 complications/1000 newborn. Their mean age was 4.8 months (2 months ? 12 months). Their presentations were: (L) axillary lymphadenitis (n= 62), (L) supraclavicular lymphadenitis (n= 9), local collection at immunization site (n= 6), (L) cervical lymphadenitis (n= 1), bilateral axillary lymphadenitis (n= 1), (L) arm abscess (n= 1) and (L) axillary lymphadenitis and local collection (n= 1). All were normal immunologically except two (SCID and HIV). These received anti-tuberculous drugs in addition to surgery. The 6 with localized collection were aspirated only while the patient with (L) arm abscess had incision and drainage. Those with simple lymphadenitis (n=5) were treated expectantly and resolved. The patients with suppurative lymphadenitis were treated with total excision (n= 65) or incision and drainage (n= 3) without anti-tuberculous treatment. Conclusions: Although, the use of BCG vaccine may be associated with side effects (a relatively high incidence of suppurative lymphadenitis), the potential morbidity and mortality from tuberculosis outweighs that from BCG related complications. BCG vaccine should be administered to all newborn where there is high prevalence of tuberculosis. BCG is contraindicated for immuodeficient infants. Non-suppurative lymphadenitis can be treated conservatively, while suppurative lymphadenitis should be excised. This is safe, avoids rupture and shortens the recovery period without the need for anti-tuberculous therapy.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Alwyn Rapose”